More compact doses for perioral treatment than for upper facial apps are applied since the oral musculature responds far more strongly to the exact same BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia.This Local community support